BIBF 1120 (esylate) - CAS# 656247-18-6 Size:Solid 10 mg 1403764-72-6

1403764-72-6

3ClH/c1-26(15-7-3-2-4-8-16-26)29-18-13-22(14-19-29)30-24-12-6-5-11-23(24)28-25(30)21-10-9-17-27-20-21

Modification of the existing maximum residue levels for valifenalate in various crops

Kenpaullone shows much less effect on c-src (IC50

Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo

BIBF 1120 (esylate) - CAS# 656247-18-6 Size:Solid 10 mg 1403764-72-6Nintedanib, also known as BIBF 1120, is an orally bioavailable inhibitor of vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR) and platelet derived growth factor receptor (PDGFR). Intedanib selectively binds to and inhibits vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR) and platelet derived growth factor receptor (PDGFR) tyrosine kinases, which may result in the